Limitations of diabetes pharmacotherapy: Results from the Vermont Diabetes Information System study

BMC Family Practice

Volumn 7, Issue , 2006, Pages

  MacLean, Charles D ^a   Littenberg, Benjamin ^a   Kennedy, Amanda G ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; INSULIN; METFORMIN; SULFONYLUREA; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; CLINICAL LABORATORY; COMMUNITY CARE; CONTROLLED STUDY; DECISION MAKING; DEMOGRAPHY; DIABETES MELLITUS; DRUG CONTRAINDICATION; FEMALE; GLYCEMIC CONTROL; HEALTH INSURANCE; HUMAN; HYPERGLYCEMIA; INFORMATION SYSTEM; INTERVIEW; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRIMARY MEDICAL CARE; UNITED STATES; CONTRAINDICATIONS; DRUG EFFECTS; DRUG UTILIZATION; GENERAL PRACTICE; GLUCOSE BLOOD LEVEL; HEALTH CARE SURVEY; HOSPITAL INFORMATION SYSTEM; MIDDLE AGED; PATHOPHYSIOLOGY; PRIMARY HEALTH CARE; RISK ASSESSMENT; RISK FACTOR; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE INFORMATION SYSTEMS; BLOOD GLUCOSE; DIABETES MELLITUS; DRUG UTILIZATION; FAMILY PRACTICE; FEMALE; HEALTH CARE SURVEYS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; RISK ASSESSMENT; RISK FACTORS; VERMONT;

EID: 33748456500     PISSN: 14712296     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-7-50     Document Type: Article

References (28)

1. Harris MI: Health care and health status and outcomes for patients with type 2 diabetes. Diabetes Care 2000, 23(6):754-758.
2. Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KM: A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med 2002, 136(8):565-574.
3. Beckles GL, Engelgau MM, Narayan KM, Herman WH, Aubert RE, Williamson DF: Population-based assessment of the level of care among adults with diabetes in the U.S. Diabetes Care 1998, 21(9):1432-1438.
4. Saydah SH, Fradkin J, Cowie CC: Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. Jama 2004, 291(3):335-342.
5. Grant RW, Pirraglia PA, Meigs JB, Singer DE: Trends in complexity of diabetes care in the United States from 1991 to 2000. Arch Intern Med 2004, 164(10):1134-1139.
6. Koro CE, Bowlin SJ, Bourgeois N, Fedder DO: Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care 2004, 27(1):17-20.
7. ADA: Standards of Medical Care in Diabetes - 2006. Diabetes Care 2006, 29(Suppl 1):S4-S42.
8. MacLean CD, Littenberg B, Gagnon MS, Reardon M, Turner PD, Jordan C: The Vermont Diabetes Information System (VDIS): Study Design and Subject Recruitment for a Cluster Randomized Trial of a Decision Support System in a Regional Sample of Primary Care Practices. Clinical Trials 2004, 1:532-544.
9. Tamborlane WV, Kollman C, Steffes MW, Ruedy KJ, Dongyuan X, Beck RW, Chase P, Fox LA, Wilson DM, Tsalikian E: Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study. Pediatr Diabetes 2005, 6(1):13-16.
10. Spearman C: The proof and measurement of association between two things. Am J Psychol 1904, 15:72-101.
11. Cuzick J: A Wilcoxon-type test for trend. Stat Med 1985, 4(1):87-90.
12. Hosmer DW, Lemeshow S: Applied Logistic Regression (2nd ed). New York , John Wiley & Sons; 2000.
13. Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN: The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum 2003, 49(2):156-163.
14. Strauss K, MacLean C, Troy A, Littenberg B: Driving distance as a barrier to glycemic control in diabetes. J Gen Intern Med 2006, 21(4):378-380.
15. Ware JE, Kosinski M, Turner-Bowker DM, Gandek B: How to Score Version 2 of the SF-12 Health Survey. Lincoln, RI , QualityMetric Inc.; 2002.
16. US_Census: Income, Poverty, and Health Insurance Coverage in the United States. [http://www.census.gov/prod/2004pubs/p60-226.pdf].
17. US_Census: Health Insurance Coverage Status and Type of Coverage by State and Age for All People. [http://pubdb3.cen sus.gov/macro/032005/health/h05_000. htm].
18. Riddle MC: The underuse of insulin therapy in North America. Diabetes Metab Res Rev 2002, 18 Suppl 3:S42-9.
19. Wright A, Burden AC, Paisey RB, Cull CA, Holman RR: Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). Diabetes Care 2002, 25(2):330-336.
20. Yki-Jarvinen H: Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus. Diabetes Metab Res Rev 2002, 18 Suppl 3:S77-81.
21. Goel A, MacLean CD, Walrath D, Rubin A, Huston D, Jones MC, Niquette T, Kennedy AG, Beardall RW, Littenberg B: Adapting root cause analysis to chronic medical conditions. Jt Comm J Qual Saf 2004, 30(4):175-186.
22. Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV: Psychological Insulin Resistance in Patients With Type 2 Diabetes: The scope of the problem. Diabetes Care 2005, 28(10):2543-2545.
23. Glucophage [package insert]. Princeton, NJ: Bristol-Myers Squibb Company. 2004.
24. Actos [package insert]. Lincolnshire, IL: Takeda Pharmaceuticals America, Inc; Indianapolis, IN: Eli Lilly and Company. 2004.
25. Avandia [package insert]. Research Triangle Park, NC: GlaxoSmithKline. 2005.
26. Eurich DT, Majumdar SR, McAlister FA, Tsuyuki RT, Johnson JA: Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care 2005, 28(10):2345-2351.
27. ADA: Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2005, 28 Suppl 1:S37-S42.
28. Aye T, Levitsky LL: Type 2 diabetes: an epidemic disease in childhood. Curr Opin Pediatr 2003, 15(4):411-415.